Exploiting TERT dependency as a therapeutic strategy for NRAS-mutant melanoma
Patricia Reyes-Uribe(The Wistar Institute), Jessie Villanueva(The Wistar Institute)
Cited by 54
Related Papers
Selective abrogation of S6K2 identifies lipid homeostasis as a survival vulnerability in MAPK inhibitor–resistant <i>NRAS</i> -mutant melanoma
|Science Translational Medicine|2025|4